NCT05544344 Healthy ReStart Intervention to Improve Health and Functioning
| NCT ID | NCT05544344 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Illinois at Chicago |
| Condition | Mental Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2022-07-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2022-07-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study tests an intervention that uses health coaching, motivational interviewing, positive psychology, and online wellness tools to help adults with mental illness return to active lives after major disruptions such as the COVID-19 pandemic.
Eligibility Criteria
Inclusion Criteria: * Age 18 and older * Diagnosis of serious mental illness defined as a DSM 5 psychiatric disorder and moderate to severe functional impairment * Membership in a collaborating community mental health agency * Access to the Internet for online meetings * Able to provide informed consent Exclusion Criteria: * A cognitive impairment preventing informed consent * Unable to communicate in English
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05544344 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Mental Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05544344 currently recruiting?
Yes, NCT05544344 is actively recruiting participants. Contact the research team at jcook@uic.edu for enrollment information.
Where is the NCT05544344 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT05544344 clinical trial?
NCT05544344 is sponsored by University of Illinois at Chicago. The trial plans to enroll 60 participants.